EMP3 and central nervous system cancer: Through comparative analysis of these groups, in the CGGA database, EMP3 was highly enriched in higher-grade gliomas (P < 0.0001, Fig. 2C) and IDH-wildtype gliomas (P < 0.0001, Fig. 2D).